This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (38)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

ALLAN L. LORINCZ, M.D.; ROGER W. PEARSON, M.D.

Arch Dermatol. 1962;85(1):2-16.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Over approximately the past 2 decades drugs of the sulfapyridine and sulfone type have become well established in dermatologic practice as uniquely effective therapeutic agents in a puzzling variety of apparently unrelated disorders. Although these drugs were primarily introduced into medical practice as antibacterial substances, clinical experience has clearly demonstrated that their action in suppressing dermatologic disorders must rest on other than their antibacterial effect. The purpose of this communication is to survey reported dermatologic experience with these drugs and to report on observations with them at The University of Chicago Clinics. In addition, the hypothesis is proposed that the abnormal tissue reactivities characterizing the disorders responsive to these drugs share in their pathomechanisms some common denominator which is blocked by them. Elucidation of this hypothetical common denominator may well provide the key to understanding the natures of the puzzling disorders under consideration, solve the problem of mechanism of action . . . [Full Text PDF of this Article]

Author Affiliations
CHICAGO

From the Section of Dermatology, Department of Medicine, The University of Chicago.

Footnotes
Submitted for publication Aug. 21, 1961.

Read before the 81st Annual Meeting of the American Dermatological Association, Inc., Tucker's Town, Bermuda, June 16, 1961.

This study was supported in part by a Research Grant from the Public Health Service, National Institute of Allergy and Infectious Diseases, Grant No. E-1444 (C5) and in part by Graduate Training Grant from the Public Health Service, National Institute of Arthritis and Metabolic Diseases, Grant No. 2A-5263(C1).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?